🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 2025 Harrington Prize for Innovation in Medicine is awarded to Dr. Owen N. Witte, MD, @dgsomuclafor for his pioneering work on tyrosine kinases that led to life-saving cancer therapies like imatinib and ibrutinib. ASCI bit.ly/4c2ax7r

Dr. Owen Witte was awarded Harrington Discovery Institute's 2025 Harrington Prize for Innovation in Medicine in recognition of his pioneering discoveries that have fundamentally reshaped the treatment of leukemia, lymphoma and other cancers. ucla.in/3FA9K1m

We’re delighted to see validation of the @AlveoGene InGenuITy® platform in use in the first inhaled lentiviral gene therapy trial for cystic fibrosis. AlveoGene is the first company in the Oxford-Harrington Accelerator following co-investment by Harrington Discovery Institute and Oxford Science Enterprises

Harrington Discovery Institute is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. This award offers successful applicants multiple opportunities for funding. Learn more and apply! tinyurl.com/5yex43bj

Harrington Discovery Institute is accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. The award offers opportunities for funding in addition to expertise from pharma-experienced leaders. Learn more and apply below. bit.ly/HarringtonScho…

We’re pleased to welcome Majid Jafar, global business leader, philanthropist, and co-founder of the Loulou Foundation, to the Advisory Council of the Oxford-Harrington Rare Disease Centre. Read more: tinyurl.com/2emjxp48

The ADDF and Harrington Discovery Institute are pleased to announce a joint RFP for the 2026 ADDF-Harrington Scholar Award, aimed at accelerating the translation of innovative research that may treat, prevent, slow, or reverse Alzheimer's or related dementias. bit.ly/2rEQkiv

May is Cystic Fibrosis Awareness Month. CF affects 105,000+ people worldwide, causing serious respiratory and digestive challenges, which require lifelong management. Harrington Discovery Institute #CFAwarenessMonth #CysticFibrosis #RareDiseases

As Chair of the Oxford-Harrington Rare Disease Centre Centre’s Advisory Board, I was delighted to join global medical leaders & researchers at the Harrington Discovery Institute & University Hospitals Scientific Symposium in Cleveland, Ohio this week. Rare disease & Alzheimer’s have been a focus personally & professionally

Last week, the Oxford-Harrington Rare Disease Centre was represented at the 12th Annual Harrington Discovery Institute Symposium. OHC Advisory Council Chair, David Cameron, joined scientific leaders to discuss drug development progress for rare diseases. Read more: shorturl.at/ri7QU

During Harrington Discovery Institute's 12th annual scientific symposium, it was my privilege to join former British Prime Minister David Cameron, Oxford-Harrington Rare Disease Centre Advisory Council Chair, and Biotechnology Innovation Organization CEO John F. Crowley, Advisory Council member, for a fireside chat. Outstanding discussion.

Our 12th annual symposium with University Hospitals Oxford-Harrington Rare Disease Centre, united global leaders to accelerate cures for Alzheimer’s, rare diseases & more, with David Cameron & John Crowley, CEO Biotechnology Innovation Organization, and Dr. Robert M. Califf More: bit.ly/45ubN1P

Congratulations to Dr. Hamed Jafar-Nejad Hamed Jafar-Nejad on your 2025 Scholar-Innovator Award from the Harrington Discovery Institute Harrington Discovery Institute! Read more about the award here: harringtondiscovery.org/news-media/202…

Announcing our 2025 Harrington Scholar-Innovators advancing treatments for diseases, including cardiovascular, inflammatory and infectious diseases and cancer, and more. 10 physician-scientists. One mission to advance breakthrough science into medicines. bit.ly/3ZdELPR

#Genomics has come a long way since I started #Genomes100k. Although there’s still a long way to go, the future is bright. Through our work at Oxford-Harrington Rare Disease Centre, new cures for #RareDiseases will be found that will have wider, positive implications for all. thetimes.co.uk/article/david-…

Lord David Cameron calls for genome sequencing for children in pediatric care to accelerate #raredisease diagnosis and treatment. As Chair of the Oxford-Harrington Rare Disease Centre Advisory Council, he highlights our mission to cure rare diseases. University Hospitals University of Oxford bit.ly/43wU8FG

Despite promising scientific advances into new therapies, many rare and ultra-rare diseases remain without treatments due to lack of funding for clinical development and trials. Image Credit: Richard Cannon Link to the full article: shorturl.at/pvyoC

Thousands of rare diseases still lack treatments—DHDDS is just one. Families are stepping in to drive progress. Oxford-Harrington Rare Disease Centre is committed to advancing innovation to turn promising science into treatments. bit.ly/46clyCc

We are proud to share that University Hospitals orthopedic physicians rank among the best in the nation for research, according to Avant-Garde Health. Read the full announcement below. bit.ly/OrthopedicRese…

A young boy who lost the ability to walk due to a rare, fatal brain disease is now running again thanks to a groundbreaking treatment developed by Michael Pacold, MD, PhD, of NYU Langone Health, a 2023 Harrington Scholar-Innovator and 2024 Oxford-Harrington Rare Disease Centre Scholar bit.ly/3GMbLbO